clinical trial · NCT05082571
Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease
Anemia of Chronic Kidney Diseasevadadustat
brief summary
This study will assess the safety and efficacy of once daily dosing of vadadustat for the treatment of pediatric participants with anemia of Chronic Kidney Disease (CKD) after conversion from an Erythropoiesis Stimulating Agent (ESA).
started
Jan 1, 2025
primary completion
Jul 1, 2026
completion
Oct 1, 2026
last updated
Oct 1, 2025
official title
A Multicenter, Open-label Study to Evaluate the Safety and Efficacy of Once Daily Oral Vadadustat for the Treatment of Pediatric Subjects With Anemia of Chronic Kidney Disease After Conversion From an Erythropoiesis-stimulating Agent
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol